Home Healthcare Healthcare Services Europe Cell and Gene Therapy Manufacturing QC Market

Europe Cell and Gene Therapy Manufacturing QC Market Size, Share & Trends Analysis Report By Therapy Type (Cell Therapy, Gene Therapy), By Scale (Pre-commercial/ R&D Manufacturing, Commercial Scale Manufacturing), By Mode (Contract Manufacturing, In-house Manufacturing), By Workflow (Cell Processing, Cell Banking, Fill & Finish Operations, Raw Material Testing, Vector Production, Other Workflows), By Process (Upstream Processes, Downstream Processes), By End-User (Pharmaceutical Companies, Biopharmaceutical / Biotechnological Companies, Contract Manufacturing Organizations), By Technology Type (Fluorescence-Activated Cell Sorting (FACS), Enzyme-Linked Immunosorbent Assay (ELISA), Chromatography, Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Others) and By Country (U.K., Germany, France, Italy, Russia, Nordic, Benelux, Rest of Europe) Forecasts, 2026-2034

Last Updated: July 08, 2026 | Author: Debashree B | Format: | Report Code: SR6219DR | Pages: 80
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Europe Cell and Gene Therapy Manufacturing QC Market, By Therapy Type 2022 (USD MILLION/ Units)
    1. Cell Therapy
      1. CAR-T
        1. Autologous CAR-T
        2. Allogeneic CAR-T
      2. CAR-NK
      3. B-Cell
      4. Others
    2. Gene Therapy
      1. Viral
        1. AAV
        2. Lentiviral vectors
        3. Other
      2. Non-Viral
  2. Europe Cell and Gene Therapy Manufacturing QC Market, By Scale 2022 (USD MILLION/ Units)
    1. Pre-commercial/ R&D Manufacturing
    2. Commercial Scale Manufacturing
  3. Europe Cell and Gene Therapy Manufacturing QC Market, By Mode 2022 (USD MILLION/ Units)
    1. Contract Manufacturing
    2. In-house Manufacturing
  4. Europe Cell and Gene Therapy Manufacturing QC Market, By Workflow 2022 (USD MILLION/ Units)
    1. Cell Processing
    2. Cell Banking
    3. Fill & Finish Operations
    4. Raw Material Testing
    5. Vector Production
    6. Other Workflows
  5. Europe Cell and Gene Therapy Manufacturing QC Market, By Process 2022 (USD MILLION/ Units)
    1. Upstream Processes
    2. Downstream Processes
  6. Europe Cell and Gene Therapy Manufacturing QC Market, By End-User 2022 (USD MILLION/ Units)
    1. Pharmaceutical Companies
      1. Small Size
      2. Medium Size
      3. Large Size
    2. Biopharmaceutical / Biotechnological Companies
      1. Small Size
      2. Medium Size
      3. Large Size
    3. Contract Manufacturing Organizations
      1. Small Size
      2. Medium Size
      3. Large Size
  7. Europe Cell and Gene Therapy Manufacturing QC Market, By Technology Type 2022 (USD MILLION/ Units)
    1. Fluorescence-Activated Cell Sorting (FACS)
    2. Enzyme-Linked Immunosorbent Assay (ELISA)
    3. Chromatography
    4. Next-Generation Sequencing (NGS)
    5. Polymerase Chain Reaction (PCR)
    6. Others
  8. Regional Europe Cell and Gene Therapy Manufacturing QC Market
    1. Europe
      1. Europe Europe Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2022 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      2. Europe Europe Cell and Gene Therapy Manufacturing QC Market By Scale 2022 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      3. Europe Europe Cell and Gene Therapy Manufacturing QC Market By Mode 2022 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      4. Europe Europe Cell and Gene Therapy Manufacturing QC Market By Workflow 2022 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      5. Europe Europe Cell and Gene Therapy Manufacturing QC Market By Process 2022 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      6. Europe Europe Cell and Gene Therapy Manufacturing QC Market By End-User 2022 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      7. Europe Europe Cell and Gene Therapy Manufacturing QC Market By Technology Type 2022 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
      8. U.K. Europe Cell and Gene Therapy Manufacturing QC Market
        1. U.K. Europe Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2022 (USD MILLION/ Units)
          1. Cell Therapy
            1. CAR-T
              1. Autologous CAR-T
              2. Allogeneic CAR-T
            2. CAR-NK
            3. B-Cell
            4. Others
          2. Gene Therapy
            1. Viral
              1. AAV
              2. Lentiviral vectors
              3. Other
            2. Non-Viral
        2. U.K. Europe Cell and Gene Therapy Manufacturing QC Market By Scale 2022 (USD MILLION/ Units)
          1. Pre-commercial/ R&D Manufacturing
          2. Commercial Scale Manufacturing
        3. U.K. Europe Cell and Gene Therapy Manufacturing QC Market By Mode 2022 (USD MILLION/ Units)
          1. Contract Manufacturing
          2. In-house Manufacturing
        4. U.K. Europe Cell and Gene Therapy Manufacturing QC Market By Workflow 2022 (USD MILLION/ Units)
          1. Cell Processing
          2. Cell Banking
          3. Fill & Finish Operations
          4. Raw Material Testing
          5. Vector Production
          6. Other Workflows
        5. U.K. Europe Cell and Gene Therapy Manufacturing QC Market By Process 2022 (USD MILLION/ Units)
          1. Upstream Processes
          2. Downstream Processes
        6. U.K. Europe Cell and Gene Therapy Manufacturing QC Market By End-User 2022 (USD MILLION/ Units)
          1. Pharmaceutical Companies
            1. Small Size
            2. Medium Size
            3. Large Size
          2. Biopharmaceutical / Biotechnological Companies
            1. Small Size
            2. Medium Size
            3. Large Size
          3. Contract Manufacturing Organizations
            1. Small Size
            2. Medium Size
            3. Large Size
        7. U.K. Europe Cell and Gene Therapy Manufacturing QC Market By Technology Type 2022 (USD MILLION/ Units)
          1. Fluorescence-Activated Cell Sorting (FACS)
          2. Enzyme-Linked Immunosorbent Assay (ELISA)
          3. Chromatography
          4. Next-Generation Sequencing (NGS)
          5. Polymerase Chain Reaction (PCR)
          6. Others
      9. Germany Europe Cell and Gene Therapy Manufacturing QC Market
        1. Germany Europe Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2022 (USD MILLION/ Units)
          1. Cell Therapy
            1. CAR-T
              1. Autologous CAR-T
              2. Allogeneic CAR-T
            2. CAR-NK
            3. B-Cell
            4. Others
          2. Gene Therapy
            1. Viral
              1. AAV
              2. Lentiviral vectors
              3. Other
            2. Non-Viral
        2. Germany Europe Cell and Gene Therapy Manufacturing QC Market By Scale 2022 (USD MILLION/ Units)
          1. Pre-commercial/ R&D Manufacturing
          2. Commercial Scale Manufacturing
        3. Germany Europe Cell and Gene Therapy Manufacturing QC Market By Mode 2022 (USD MILLION/ Units)
          1. Contract Manufacturing
          2. In-house Manufacturing
        4. Germany Europe Cell and Gene Therapy Manufacturing QC Market By Workflow 2022 (USD MILLION/ Units)
          1. Cell Processing
          2. Cell Banking
          3. Fill & Finish Operations
          4. Raw Material Testing
          5. Vector Production
          6. Other Workflows
        5. Germany Europe Cell and Gene Therapy Manufacturing QC Market By Process 2022 (USD MILLION/ Units)
          1. Upstream Processes
          2. Downstream Processes
        6. Germany Europe Cell and Gene Therapy Manufacturing QC Market By End-User 2022 (USD MILLION/ Units)
          1. Pharmaceutical Companies
            1. Small Size
            2. Medium Size
            3. Large Size
          2. Biopharmaceutical / Biotechnological Companies
            1. Small Size
            2. Medium Size
            3. Large Size
          3. Contract Manufacturing Organizations
            1. Small Size
            2. Medium Size
            3. Large Size
        7. Germany Europe Cell and Gene Therapy Manufacturing QC Market By Technology Type 2022 (USD MILLION/ Units)
          1. Fluorescence-Activated Cell Sorting (FACS)
          2. Enzyme-Linked Immunosorbent Assay (ELISA)
          3. Chromatography
          4. Next-Generation Sequencing (NGS)
          5. Polymerase Chain Reaction (PCR)
          6. Others
      10. France Europe Cell and Gene Therapy Manufacturing QC Market
        1. France Europe Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2022 (USD MILLION/ Units)
          1. Cell Therapy
            1. CAR-T
              1. Autologous CAR-T
              2. Allogeneic CAR-T
            2. CAR-NK
            3. B-Cell
            4. Others
          2. Gene Therapy
            1. Viral
              1. AAV
              2. Lentiviral vectors
              3. Other
            2. Non-Viral
        2. France Europe Cell and Gene Therapy Manufacturing QC Market By Scale 2022 (USD MILLION/ Units)
          1. Pre-commercial/ R&D Manufacturing
          2. Commercial Scale Manufacturing
        3. France Europe Cell and Gene Therapy Manufacturing QC Market By Mode 2022 (USD MILLION/ Units)
          1. Contract Manufacturing
          2. In-house Manufacturing
        4. France Europe Cell and Gene Therapy Manufacturing QC Market By Workflow 2022 (USD MILLION/ Units)
          1. Cell Processing
          2. Cell Banking
          3. Fill & Finish Operations
          4. Raw Material Testing
          5. Vector Production
          6. Other Workflows
        5. France Europe Cell and Gene Therapy Manufacturing QC Market By Process 2022 (USD MILLION/ Units)
          1. Upstream Processes
          2. Downstream Processes
        6. France Europe Cell and Gene Therapy Manufacturing QC Market By End-User 2022 (USD MILLION/ Units)
          1. Pharmaceutical Companies
            1. Small Size
            2. Medium Size
            3. Large Size
          2. Biopharmaceutical / Biotechnological Companies
            1. Small Size
            2. Medium Size
            3. Large Size
          3. Contract Manufacturing Organizations
            1. Small Size
            2. Medium Size
            3. Large Size
        7. France Europe Cell and Gene Therapy Manufacturing QC Market By Technology Type 2022 (USD MILLION/ Units)
          1. Fluorescence-Activated Cell Sorting (FACS)
          2. Enzyme-Linked Immunosorbent Assay (ELISA)
          3. Chromatography
          4. Next-Generation Sequencing (NGS)
          5. Polymerase Chain Reaction (PCR)
          6. Others
      11. Italy Europe Cell and Gene Therapy Manufacturing QC Market
        1. Italy Europe Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2022 (USD MILLION/ Units)
          1. Cell Therapy
            1. CAR-T
              1. Autologous CAR-T
              2. Allogeneic CAR-T
            2. CAR-NK
            3. B-Cell
            4. Others
          2. Gene Therapy
            1. Viral
              1. AAV
              2. Lentiviral vectors
              3. Other
            2. Non-Viral
        2. Italy Europe Cell and Gene Therapy Manufacturing QC Market By Scale 2022 (USD MILLION/ Units)
          1. Pre-commercial/ R&D Manufacturing
          2. Commercial Scale Manufacturing
        3. Italy Europe Cell and Gene Therapy Manufacturing QC Market By Mode 2022 (USD MILLION/ Units)
          1. Contract Manufacturing
          2. In-house Manufacturing
        4. Italy Europe Cell and Gene Therapy Manufacturing QC Market By Workflow 2022 (USD MILLION/ Units)
          1. Cell Processing
          2. Cell Banking
          3. Fill & Finish Operations
          4. Raw Material Testing
          5. Vector Production
          6. Other Workflows
        5. Italy Europe Cell and Gene Therapy Manufacturing QC Market By Process 2022 (USD MILLION/ Units)
          1. Upstream Processes
          2. Downstream Processes
        6. Italy Europe Cell and Gene Therapy Manufacturing QC Market By End-User 2022 (USD MILLION/ Units)
          1. Pharmaceutical Companies
            1. Small Size
            2. Medium Size
            3. Large Size
          2. Biopharmaceutical / Biotechnological Companies
            1. Small Size
            2. Medium Size
            3. Large Size
          3. Contract Manufacturing Organizations
            1. Small Size
            2. Medium Size
            3. Large Size
        7. Italy Europe Cell and Gene Therapy Manufacturing QC Market By Technology Type 2022 (USD MILLION/ Units)
          1. Fluorescence-Activated Cell Sorting (FACS)
          2. Enzyme-Linked Immunosorbent Assay (ELISA)
          3. Chromatography
          4. Next-Generation Sequencing (NGS)
          5. Polymerase Chain Reaction (PCR)
          6. Others
      12. Russia Europe Cell and Gene Therapy Manufacturing QC Market
        1. Russia Europe Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2022 (USD MILLION/ Units)
          1. Cell Therapy
            1. CAR-T
              1. Autologous CAR-T
              2. Allogeneic CAR-T
            2. CAR-NK
            3. B-Cell
            4. Others
          2. Gene Therapy
            1. Viral
              1. AAV
              2. Lentiviral vectors
              3. Other
            2. Non-Viral
        2. Russia Europe Cell and Gene Therapy Manufacturing QC Market By Scale 2022 (USD MILLION/ Units)
          1. Pre-commercial/ R&D Manufacturing
          2. Commercial Scale Manufacturing
        3. Russia Europe Cell and Gene Therapy Manufacturing QC Market By Mode 2022 (USD MILLION/ Units)
          1. Contract Manufacturing
          2. In-house Manufacturing
        4. Russia Europe Cell and Gene Therapy Manufacturing QC Market By Workflow 2022 (USD MILLION/ Units)
          1. Cell Processing
          2. Cell Banking
          3. Fill & Finish Operations
          4. Raw Material Testing
          5. Vector Production
          6. Other Workflows
        5. Russia Europe Cell and Gene Therapy Manufacturing QC Market By Process 2022 (USD MILLION/ Units)
          1. Upstream Processes
          2. Downstream Processes
        6. Russia Europe Cell and Gene Therapy Manufacturing QC Market By End-User 2022 (USD MILLION/ Units)
          1. Pharmaceutical Companies
            1. Small Size
            2. Medium Size
            3. Large Size
          2. Biopharmaceutical / Biotechnological Companies
            1. Small Size
            2. Medium Size
            3. Large Size
          3. Contract Manufacturing Organizations
            1. Small Size
            2. Medium Size
            3. Large Size
        7. Russia Europe Cell and Gene Therapy Manufacturing QC Market By Technology Type 2022 (USD MILLION/ Units)
          1. Fluorescence-Activated Cell Sorting (FACS)
          2. Enzyme-Linked Immunosorbent Assay (ELISA)
          3. Chromatography
          4. Next-Generation Sequencing (NGS)
          5. Polymerase Chain Reaction (PCR)
          6. Others
      13. Nordic Europe Cell and Gene Therapy Manufacturing QC Market
        1. Nordic Europe Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2022 (USD MILLION/ Units)
          1. Cell Therapy
            1. CAR-T
              1. Autologous CAR-T
              2. Allogeneic CAR-T
            2. CAR-NK
            3. B-Cell
            4. Others
          2. Gene Therapy
            1. Viral
              1. AAV
              2. Lentiviral vectors
              3. Other
            2. Non-Viral
        2. Nordic Europe Cell and Gene Therapy Manufacturing QC Market By Scale 2022 (USD MILLION/ Units)
          1. Pre-commercial/ R&D Manufacturing
          2. Commercial Scale Manufacturing
        3. Nordic Europe Cell and Gene Therapy Manufacturing QC Market By Mode 2022 (USD MILLION/ Units)
          1. Contract Manufacturing
          2. In-house Manufacturing
        4. Nordic Europe Cell and Gene Therapy Manufacturing QC Market By Workflow 2022 (USD MILLION/ Units)
          1. Cell Processing
          2. Cell Banking
          3. Fill & Finish Operations
          4. Raw Material Testing
          5. Vector Production
          6. Other Workflows
        5. Nordic Europe Cell and Gene Therapy Manufacturing QC Market By Process 2022 (USD MILLION/ Units)
          1. Upstream Processes
          2. Downstream Processes
        6. Nordic Europe Cell and Gene Therapy Manufacturing QC Market By End-User 2022 (USD MILLION/ Units)
          1. Pharmaceutical Companies
            1. Small Size
            2. Medium Size
            3. Large Size
          2. Biopharmaceutical / Biotechnological Companies
            1. Small Size
            2. Medium Size
            3. Large Size
          3. Contract Manufacturing Organizations
            1. Small Size
            2. Medium Size
            3. Large Size
        7. Nordic Europe Cell and Gene Therapy Manufacturing QC Market By Technology Type 2022 (USD MILLION/ Units)
          1. Fluorescence-Activated Cell Sorting (FACS)
          2. Enzyme-Linked Immunosorbent Assay (ELISA)
          3. Chromatography
          4. Next-Generation Sequencing (NGS)
          5. Polymerase Chain Reaction (PCR)
          6. Others
      14. Benelux Europe Cell and Gene Therapy Manufacturing QC Market
        1. Benelux Europe Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2022 (USD MILLION/ Units)
          1. Cell Therapy
            1. CAR-T
              1. Autologous CAR-T
              2. Allogeneic CAR-T
            2. CAR-NK
            3. B-Cell
            4. Others
          2. Gene Therapy
            1. Viral
              1. AAV
              2. Lentiviral vectors
              3. Other
            2. Non-Viral
        2. Benelux Europe Cell and Gene Therapy Manufacturing QC Market By Scale 2022 (USD MILLION/ Units)
          1. Pre-commercial/ R&D Manufacturing
          2. Commercial Scale Manufacturing
        3. Benelux Europe Cell and Gene Therapy Manufacturing QC Market By Mode 2022 (USD MILLION/ Units)
          1. Contract Manufacturing
          2. In-house Manufacturing
        4. Benelux Europe Cell and Gene Therapy Manufacturing QC Market By Workflow 2022 (USD MILLION/ Units)
          1. Cell Processing
          2. Cell Banking
          3. Fill & Finish Operations
          4. Raw Material Testing
          5. Vector Production
          6. Other Workflows
        5. Benelux Europe Cell and Gene Therapy Manufacturing QC Market By Process 2022 (USD MILLION/ Units)
          1. Upstream Processes
          2. Downstream Processes
        6. Benelux Europe Cell and Gene Therapy Manufacturing QC Market By End-User 2022 (USD MILLION/ Units)
          1. Pharmaceutical Companies
            1. Small Size
            2. Medium Size
            3. Large Size
          2. Biopharmaceutical / Biotechnological Companies
            1. Small Size
            2. Medium Size
            3. Large Size
          3. Contract Manufacturing Organizations
            1. Small Size
            2. Medium Size
            3. Large Size
        7. Benelux Europe Cell and Gene Therapy Manufacturing QC Market By Technology Type 2022 (USD MILLION/ Units)
          1. Fluorescence-Activated Cell Sorting (FACS)
          2. Enzyme-Linked Immunosorbent Assay (ELISA)
          3. Chromatography
          4. Next-Generation Sequencing (NGS)
          5. Polymerase Chain Reaction (PCR)
          6. Others
      15. Rest of Europe Europe Cell and Gene Therapy Manufacturing QC Market
        1. Rest of Europe Europe Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2022 (USD MILLION/ Units)
          1. Cell Therapy
            1. CAR-T
              1. Autologous CAR-T
              2. Allogeneic CAR-T
            2. CAR-NK
            3. B-Cell
            4. Others
          2. Gene Therapy
            1. Viral
              1. AAV
              2. Lentiviral vectors
              3. Other
            2. Non-Viral
        2. Rest of Europe Europe Cell and Gene Therapy Manufacturing QC Market By Scale 2022 (USD MILLION/ Units)
          1. Pre-commercial/ R&D Manufacturing
          2. Commercial Scale Manufacturing
        3. Rest of Europe Europe Cell and Gene Therapy Manufacturing QC Market By Mode 2022 (USD MILLION/ Units)
          1. Contract Manufacturing
          2. In-house Manufacturing
        4. Rest of Europe Europe Cell and Gene Therapy Manufacturing QC Market By Workflow 2022 (USD MILLION/ Units)
          1. Cell Processing
          2. Cell Banking
          3. Fill & Finish Operations
          4. Raw Material Testing
          5. Vector Production
          6. Other Workflows
        5. Rest of Europe Europe Cell and Gene Therapy Manufacturing QC Market By Process 2022 (USD MILLION/ Units)
          1. Upstream Processes
          2. Downstream Processes
        6. Rest of Europe Europe Cell and Gene Therapy Manufacturing QC Market By End-User 2022 (USD MILLION/ Units)
          1. Pharmaceutical Companies
            1. Small Size
            2. Medium Size
            3. Large Size
          2. Biopharmaceutical / Biotechnological Companies
            1. Small Size
            2. Medium Size
            3. Large Size
          3. Contract Manufacturing Organizations
            1. Small Size
            2. Medium Size
            3. Large Size
        7. Rest of Europe Europe Cell and Gene Therapy Manufacturing QC Market By Technology Type 2022 (USD MILLION/ Units)
          1. Fluorescence-Activated Cell Sorting (FACS)
          2. Enzyme-Linked Immunosorbent Assay (ELISA)
          3. Chromatography
          4. Next-Generation Sequencing (NGS)
          5. Polymerase Chain Reaction (PCR)
          6. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.